Cytokinetics (CYTK) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $74.45 +0.46%
EPS Growth %: +43.1%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +43.1%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.36), $0.01 better than the analyst estimate of ($1.37). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $3.6 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target
- Wholesale Inventories (Jul F) 1.3% vs 1.3% Expected
- DA Davidson Reiterates Buy Rating on EVI Industries Inc. (EVI) Following Q4 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
